Exabis Library
Welcome to the e-CCO Library!
P469 Stay in class or switch out of class after anti-TNF failure in inflammatory bowel disease (IBD). Real-world data from a large district general hospital
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patients
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P469: Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P469: Effectiveness of dose optimisation by pre-genotyping NUDT 15 R139C on reducing thiopurine-induced leucopoenia in Chinese patients with Crohn’s disease: a randomised controlled trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P469: Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic review
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P469: Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P469: Self-reported cutaneous side effects of anti-TNF therapy in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P469: The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P470 The concept of illness identity in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P470: Comparative effectiveness analysis of flares, hospitalisations, and corticosteroid use among biologic naïve patients with inflammatory bowel disease within 12 months of initiation of vedolizumab or infliximab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P470: DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P470: Evolution of asymptomatic unresected lesions in patients operated for multifocal Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P470: Improving IBD-related pregnancy knowledge with a specialised preconception and pregnancy in IBD clinic
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P470: Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P471 What is the appropriate cut-off value of CRP to predict endoscopic remission in ulcerative colitis patients with clinical remission?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P471: A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P471: Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P471: Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real-world specialised hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM